Abaxis, Inc. to Present at Sidoti & Company's Thirteenth Annual New York Emerging Growth Institutional Investor Forum
17 3월 2009 - 8:00PM
PR Newswire (US)
UNION CITY, Calif., March 17 /PRNewswire-FirstCall/ -- Abaxis, Inc.
(NASDAQ:ABAX), a medical products company manufacturing
point-of-care blood analysis systems, announced today that Clint
Severson, chairman and chief executive officer, will present at the
Sidoti & Company's Thirteenth Annual New York Emerging Growth
Institutional Investor Forum on Tuesday, March 24, 2009 at 10:25
a.m. ET. The conference will be held at The Grand Hyatt Hotel in
New York, NY. About Abaxis Abaxis develops, manufactures and
markets portable blood analysis systems for use in any veterinary
or human patient-care setting to provide clinicians with rapid
blood constituent measurements. The system consists of a compact,
5.1 kilogram (11.2 pounds), portable analyzer and a series of
single-use plastic discs, called reagent discs that contain all the
chemicals required to perform a panel of up to 13 tests on
veterinary patients and 14 tests on human patients. The system can
be operated with minimal training and performs multiple routine
tests on whole blood, serum or plasma samples. The system provides
test results in less than 12 minutes with the precision and
accuracy equivalent to a clinical laboratory analyzer. Contact:
Clint Severson Lytham Partners, LLC Chief Executive Officer Joe
Dorame, Joe Diaz & Robert Blum ABAXIS, Inc. 602-889-9700
510-675-6500 DATASOURCE: Abaxis, Inc. CONTACT: Clint Severson,
Chief Executive Officer of ABAXIS, Inc., +1-510-675-6500; or Joe
Dorame, Joe Diaz and Robert Blum, all of Lytham Partners, LLC,
+1-602-889-9700, for Abaxis, Inc.
Copyright
Abaxis, Inc. (delisted) (NASDAQ:ABAX)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Abaxis, Inc. (delisted) (NASDAQ:ABAX)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
Abaxis, Inc. (delisted) (나스닥)의 실시간 뉴스: 최근 기사 0
More Abaxis (MM) News Articles